000 | 01940 a2200517 4500 | ||
---|---|---|---|
005 | 20250515080901.0 | ||
264 | 0 | _c20080102 | |
008 | 200801s 0 0 eng d | ||
022 | _a0021-972X | ||
024 | 7 |
_a10.1210/jc.2007-0671 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMauras, Nelly | |
245 | 0 | 0 |
_aMetabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with turner syndrome. _h[electronic resource] |
260 |
_bThe Journal of clinical endocrinology and metabolism _cNov 2007 |
||
300 |
_a4154-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Cutaneous |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aBody Composition _xdrug effects |
650 | 0 | 4 |
_aBody Height _xdrug effects |
650 | 0 | 4 | _aBody Mass Index |
650 | 0 | 4 | _aCalorimetry, Indirect |
650 | 0 | 4 |
_aCarbohydrate Metabolism _xdrug effects |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aDietary Proteins _xmetabolism |
650 | 0 | 4 |
_aEstrogens _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinogen _xmetabolism |
650 | 0 | 4 |
_aGrowth Hormone _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInsulin-Like Growth Factor Binding Protein 3 _xblood |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
650 | 0 | 4 |
_aLipolysis _xdrug effects |
650 | 0 | 4 | _aOxidation-Reduction |
650 | 0 | 4 |
_aTurner Syndrome _xdrug therapy |
700 | 1 | _aShulman, Dorothy | |
700 | 1 | _aHsiang, Helen Y | |
700 | 1 | _aBalagopal, Prabhakaran | |
700 | 1 | _aWelch, Susan | |
773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 92 _gno. 11 _gp. 4154-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2007-0671 _zAvailable from publisher's website |
999 |
_c17242681 _d17242681 |